FDA Issues Guidance On Collection Of Race/Ethnicity Data In Clinical Trials
This article was originally published in The Gray Sheet
Executive Summary
An FDA draft guidance to aid in collection of standardized race and ethnicity information in clinical trials applies to devices as well as drugs